Century Next Financial Corporation to Deregister Its Common

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Century Next Financial Corporation to Deregister Its Common Stock

RUSTON, La., Oct. 2, 2013 (GLOBE NEWSWIRE) -- Century Next Financial Corporation (OTCBB: CTUY ), the holding company of Bank of Ruston (the "Bank"), announced today that because its common stock is currently held by less than 300 holders of record, it will terminate the registration of its common stock under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), by filing a Form 15 with the U.S. Securities and Exchange Commission ("SEC") in early October 2013.

The Company is taking this action in order to reduce the legal, accounting, and administrative costs associated with being a reporting company under the Exchange Act. William D. Hogan, President and Chief Executive Officer of the Company, stated, "We carefully considered the advantages and disadvantages of being a public company in light of our size and market capitalization and the costs and demands of ongoing compliance with SEC requirements. With this in mind, the Board decided that it is in the best interests of the Company and existing shareholders to deregister." 

Upon filing the Form 15 with the SEC, the obligations of the Company to file certain periodic reports, including Forms 10-K, 10-Q, and 8-K, will be immediately suspended. The Company anticipates that its common stock will continue to be quoted on the OTC Bulletin Board ("OTCBB") after deregistration to the extent market makers agree to make a market in its stock. No guarantee, however, can be made that a trading market in the Company's common stock through the OTCBB will be maintained.

The Company intends to continue to provide shareholders with financial information on a quarterly and annual basis through its website: www.bankruston.com . In addition, both the Company and the Bank will continue to provide semi-annual and quarterly financial reports to the Federal Reserve and the Office of the Comptroller of the Currency, as required, and intend to continue to meet all applicable auditing standards as a regulated financial institution.

Additional Information

Bank of Ruston, the wholly-owned subsidiary of Century Next Financial Corporation, has served Ruston, Lincoln Parish, Louisiana, and the surrounding area since 1905. The Bank is a full-service bank with two banking offices in Ruston. The Bank emphasizes professional and personal banking service directed primarily to small and medium-sized businesses, professionals, and individuals. The Bank provides a full range of banking services including its primary business of real estate lending to residential and commercial customers.

Forward Looking Information

Statements contained in this news release which are not historical facts may be forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties which could cause actual results to differ materially from those currently anticipated due to a number of factors, including, but not limited to, the Company's ability to realize anticipated cost savings from its deregistration; the ability to timely and effectively implement its deregistration plans; adverse effects on share price and liquidity following the Company's deregistration as well as more general business and financial risks, including the risks detailed from time to time in our filings with the SEC. We undertake no obligation to update any forward-looking statements.

William D. Hogan, President & Chief Executive Officer or Mark A. Taylor, CPA, Senior Vice President & Chief Financial Officer (318) 255-3733 Company Website: www.bankruston.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Can Take Charge in Outset Medical Securities Case

Updated Category News Views 226

Investors Can Take Control in Outset Medical Securities Case Investors seeking justice now have a valuable opportunity to take the lead in a class action lawsuit against Outset Medical, Inc. (NASDAQ: OM). This legal effort arises from claims suggesting that the company may not have been fully transparent about its product marketing and operational practices. Understanding...

Continue Reading
Understanding Market Dynamics for IDEXX Laboratories (IDXX)

Updated Category News Views 140

Insights into IDEXX Laboratories Option Trading In recent times, there has been a notable bearish sentiment among major investors regarding IDEXX Laboratories. Taking a closer look at the trading activities surrounding this stock, our attention shifts towards its options market dynamics. Recent Trading Patterns Analyzing the options history for IDEXX Laboratories (NASDAQ:...

Continue Reading
Upcoming Earnings Reports and Market Insights for Investors

Updated Category News Views 164

Key Companies Reporting Earnings Soon As investors gear up for a busy earnings week, a variety of companies are set to disclose their quarterly results. These reports often provide valuable insights into business performance and market trends. Companies Scheduled to Report Before Market Opens So-Young International Inc (NASDAQ: SY) So-Young is anticipated to announce its...

Continue Reading
Intelligent Alpha Launches Innovative AI-Driven ETF for Investors

Updated Category News Views 269

Welcome to Intelligent Alpha and AI-Driven Investments In today's fast-paced investment world, Doug Clinton, co-founder and Managing Partner at Deepwater Asset Management, has introduced Intelligent Alpha, a groundbreaking investment firm focused on utilizing the power of artificial intelligence. This unique firm distinguishes itself by having an investment committee that...

Continue Reading
Investors of Lineage, Inc. (LINE) Consider Class Action Suit

Updated Category News Views 141

Class Action Lawsuit Against Lineage, Inc. In the financial landscape, every investor hopes to see growth in their investments. However, recent developments with Lineage, Inc. have prompted concern among shareholders. It has come to light that some investors may have sustained losses due to alleged securities fraud surrounding the company's performance. As a result, legal...

Continue Reading